相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
Raphael Bueno et al.
NATURE GENETICS (2016)
Searching for targets for the systemic therapy of mesothelioma
R. A. Stahel et al.
ANNALS OF ONCOLOGY (2015)
Hippo Pathway Gene Mutations in Malignant Mesothelioma Revealed by RNA and Targeted Exon Sequencing
Akihiko Miyanaga et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Targeted Next-Generation Sequencing of Cancer Genes in Advanced Stage Malignant Pleural Mesothelioma A Retrospective Study
Marco Lo Iacono et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
A New Prognostic Score Supporting Treatment Allocation for Multimodality Therapy for Malignant Pleural Mesothelioma A Review of 12 Years' Experience
Isabelle Opitz et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Significant Association of Oncogene YAP1 with Poor Prognosis and Cetuximab Resistance in Colorectal Cancer Patients
Keun-Wook Lee et al.
CLINICAL CANCER RESEARCH (2015)
Evaluation of imaging techniques for the assessment of tumour progression in an orthotopic rat model of malignant pleural mesothelioma
Mayura Meerang et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2015)
Merlin/NF2 Loss-Driven Tumorigenesis Linked to CRL4DcAF1-Mediated Inhibition of the Hippo Pathway Kinases Latsl and 2 in the Nucleus
Wei Li et al.
CANCER CELL (2014)
PI3K/mTOR Signaling in Mesothelioma Patients Treated with Induction Chemotherapy Followed by Extrapleural Pneumonectomy
Byron K. Y. Bitanihirwe et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Merlin Deficiency Predicts FAK Inhibitor Sensitivity: A Synthetic Lethal Relationship
Irina M. Shapiro et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Is survivin expression prognostic or predictive in malignant pleural mesothelioma?
Julija Hmeljak et al.
VIRCHOWS ARCHIV (2013)
Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus
Wei Li et al.
EMBO REPORTS (2012)
TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth
Makiko Fujii et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes
T. Mizuno et al.
ONCOGENE (2012)
LATS2 Is a Tumor Suppressor Gene of Malignant Mesothelioma
Hideki Murakami et al.
CANCER RESEARCH (2011)
Malignant pleural mesothelioma: The standard of care and challenges for future management
Jan P. van Meerbeeck et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
Global Magnitude of Reported and Unreported Mesothelioma
Eun-Kee Park et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2011)
Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: An exploratory analysis
Roy Sidi et al.
EUROPEAN JOURNAL OF CANCER (2011)
Mammalian Hippo pathway: from development to cancer and beyond
Yijun Bao et al.
JOURNAL OF BIOCHEMISTRY (2011)
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
Matthew Bott et al.
NATURE GENETICS (2011)
Merlin/NF2 Suppresses Tumorigenesis by Inhibiting the E3 Ubiquitin Ligase CRL4DCAF1 in the Nucleus
Wei Li et al.
CELL (2010)
The Hippo Signaling Pathway in Development and Cancer
Duojia Pan
DEVELOPMENTAL CELL (2010)
Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: A phase II prospective study
Tamara R. Tilleman et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2009)
NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth
Marianne F. James et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Functional inactivation of NF2/merlin in human mesothelioma
Claudio Thurneysen et al.
LUNG CANCER (2009)
TEAD mediates YAP-dependent gene induction and growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2008)
Opinion - Survivin, cancer networks and pathway-directed drug discovery
Dario C. Altieri
NATURE REVIEWS CANCER (2008)
Filling out the Hippo pathway
Leslie J. Saucedo et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Nuclear and cytoplasmic survivin: Molecular mechanism, prognostic, and therapeutic potential
Roland H. Stauber et al.
CANCER RESEARCH (2007)
D2-40 and calretinin - a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation
Marc Hinterberger et al.
MODERN PATHOLOGY (2007)
Evaluation of NF2 gene deletion in sporadic schwannomas, meningiomas, and ependymomas by chromogenic in situ hybridization
Maria D. Begnami et al.
HUMAN PATHOLOGY (2007)
Nuclear or cytoplasmic expression of survivin: What is the significance?
FZ Li et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Cell cycle-dependent nucleocytoplasmic shuttling of the neurofibromatosis 2 tumour suppressor merlin
T Muranen et al.
ONCOGENE (2005)
Nucleocytoplasmic transfer of the NF2 tumor suppressor protein merlin is regulated by exon 2 and a CRM1-dependent nuclear export signal in exon 15
M Kressel et al.
HUMAN MOLECULAR GENETICS (2002)
分享论文
